Paradigm Health today announced its role in the execution of a multicenter, hybrid, observational post-marketing commitment study in the United States evaluating an FDA-approved therapy in patients ...
Today, Paradigm Health announced the launch of a landmark research collaboration with the U.S. Food & Drug Administration (FDA) focused on advancing a new model to accelerate clinical trial execution ...
Takeda Pharmaceutical to Acquire Paradigm Therapeutics Limited OSAKA, Japan & CAMBRIDGE, England -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and Paradigm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results